Tag: Medical Community

Jill Littrell, Ph.D. explores neuroscience and physiological explanations behind diagnostic categories of mental illness

Jill Littrell’s new book, Neuroscience for Psychologists and Other Mental Health Professionals: Promoting Well-Being and Treating Mental Illness, presents the latest neuroscience and physiological explanations behind the major diagnostic categories of mental illness—including schizophrenia, depression, anxiety, and addiction—and explains the physiological bases that underlie traditional pharmaceutical treatment interventions.  Of particular note in the book is cutting-edge information …

Read more

Diagnostic Criteria for AE Released

A newly released precis provides clear diagnostic criteria for autoimmune encephalitis. This effort, lead by Dr. Domingo Escudero, Dr. Francesc Graus and Dr. Josep Dalmau, summarizes the Lancet Neurology article “A clinical approach to autoimmune encephalitis“. The Lancet Neurology article  provides the first broadly accepted criteria for diagnosing autoimmune encephalitis.  A previous AE Alliance blog reviewed the article and it’s connection to the first International …

Read more

Brazilian scientists find new Zika-linked brain disorder in adults

The following article was published by Rueters on April 11, 2016. “The new discovery now shows Zika may provoke an immune attack on the central nervous system as well.” Brazilian scientists have found a that there is a link between Zika and an autoimmune syndrome called acute disseminated encephalomyelitis, that attacks the brain and spinal cord. Zika, a mosquito-borne …

Read more

Rituximab shows second-line promise in autoimmune limbic encephalitis

“Rituximab is effective and safe as a second-line immunotherapy for autoimmune limbic encephalitis, regardless of autoantibody status. Additional monthly rituximab therapy might potentiate the efficacy of rituximab,” concludes the authors of this Rituximab study published in medical journal, Neurology.  Lucy Piper of News Medical, an online, open-access medical information provider has published the article”Rituximab shows second-line promise in …

Read more

Dr. Luca Bartolini creates survey on best practices to treat anti-NMDA receptor encephalitis

The following information was provided by Neurology, the official journal of the American Academy of Neurology. In the absence of data from clinical trials, anecdotal experience and expert opinion become the main source of knowledge on which medical decisions are made to treat anti-NMDA encephalitis. Clinical approaches and decision-making are apt to change over time …

Read more

England’s National Health Service releases evidence review on Intravenous Immunoglobulin for AE

The National Health Service of England published the following review of IVIg for treatment of autoimmune encephalitis. The report was released in January 2016. “Evidence Review: Intravenous immunoglobulin for autoimmune encephalitis” Autoimmune encephalitis (AIE) is used to describe a group of disorders characterised by symptoms of limbic and extra-limbic dysfunction occurring in association with antibodies …

Read more

The Lancet publishes first broadly accepted criteria for diagnosing autoimmune encephalitis

Today The Lancet released an important paper from Dr. Dalmau et al., providing the first broadly accepted criteria for diagnosing autoimmune encephalitis. Included in the paper are guidelines for diagnosing anti-body negative AE, a frustratingly difficult subset of AE cases to diagnose and thus treat. Many of the paper’s authors attended the International Symposium on Autoimmune …

Read more

University of North Carolina at Chapel Hill offering course on effectively dealing with autoimmune diseases

As part of UNC’s School of Medicine, the “Program on Integrative Medicine,”  is offering a five week course titled “The Immunology of Autoimmune Disease, Inflammation and Chronic Infection: A Research-Based Functional Medicine Perspective.” WEDNESDAYS: 6:30pm-8:30pm, February 17– March 16, 2016. ***Please note change in course dates*** Taught by Dr. Sam Yanuck, whose functional medicine practice …

Read more

New study on body’s response to inflammatory pathogens could lead to new therapeutic controls

The body can control inflammatory response triggered by invasions of microbial pathogens, such as bacteria and viruses, a discovery that could lead to the development of new therapeutic agents for uncontrolled inflammation, according to researchers at Georgia State University. Read the fill article at Inflammatory Response Study .

Read more